Menu
GWAS Study

Genome wide association study and genomic risk prediction of age related macular degeneration in Israel.

Grunin M, Triffon D, Beykin G et al.

38844476 PubMed ID
GWAS Study Type
883 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GM
Grunin M
TD
Triffon D
BG
Beykin G
RE
Rahmani E
SR
Schweiger R
TL
Tiosano L
KS
Khateb S
HS
Hagbi-Levi S
RB
Rinsky B
MR
Munitz R
WT
Winkler TW
HI
Heid IM
HE
Halperin E
CS
Carmi S
CI
Chowers I
Chapter II

Abstract

Summary of the research findings

The risk of developing age-related macular degeneration (AMD) is influenced by genetic background. In 2016, the International AMD Genomics Consortium (IAMDGC) identified 52 risk variants in 34 loci, and a polygenic risk score (PRS) from these variants was associated with AMD. The Israeli population has a unique genetic composition: Ashkenazi Jewish (AJ), Jewish non-Ashkenazi, and Arab sub-populations. We aimed to perform a genome-wide association study (GWAS) for AMD in Israel, and to evaluate PRSs for AMD. Our discovery set recruited 403 AMD patients and 256 controls at Hadassah Medical Center. We genotyped individuals via custom exome chip. We imputed non-typed variants using cosmopolitan and AJ reference panels. We recruited additional 155 cases and 69 controls for validation. To evaluate predictive power of PRSs for AMD, we used IAMDGC summary-statistics excluding our study and developed PRSs via clumping/thresholding or LDpred2. In our discovery set, 31/34 loci reported by IAMDGC were AMD-associated (P < 0.05). Of those, all effects were directionally consistent with IAMDGC and 11 loci had a P-value under Bonferroni-corrected threshold (0.05/34 = 0.0015). At a 5 × 10-5 threshold, we discovered four suggestive associations in FAM189A1, IGDCC4, C7orf50, and CNTNAP4. Only the FAM189A1 variant was AMD-associated in the replication cohort after Bonferroni-correction. A prediction model including LDpred2-based PRS + covariates had an AUC of 0.82 (95% CI 0.79-0.85) and performed better than covariates-only model (P = 5.1 × 10-9). Therefore, previously reported AMD-associated loci were nominally associated with AMD in Israel. A PRS developed based on a large international study is predictive in Israeli populations.

242 Ashkenazi Jewish ancestry cases, 136 Ashkenazi Jewish ancestry controls, 161 North African, Sephardi, Turkish, Arab or Israeli ancestry cases, 120 North African, Sephardi, Turkish, Arab or Israeli ancestry controls

Chapter III

Study Statistics

Key metrics and study information

883
Total Participants
GWAS
Study Type
Yes
Replicated
155 Israeli ancestry cases, 69 Israeli ancestry controls
Replication Participants
Other, Greater Middle Eastern (Middle Eastern, North African or Persian), NR
Ancestry
Israel
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.